Dr. Sarman Singh, obtained his MBBS degree from prestigious King George’s Medical College, Lucknow (1982), and MD (Doctor of Medicine) degree from Post Graduate Institute of Medical Education and Research Chandigarh India (1987). After that in 1990 he was trained in epidemiology of Infectious diseases at University of Michigan, Ann Arbor, USA and Animal Research Ethics at Rosalind Franklin University, Chicago, USA in 1994. In July 2000 he completed the certificate course in Ethical Issues in International Health Research organised jointly by Harvard and Tuft Universities of USA and Univ. of Natal, South Africa, at Natal, South Africa. 

After joining the premier All India Institute of Medical Sciences (AIIMS), New Delhi in 1988, he served at this Institute for more than 30 years in various faculty positions. Prof. Singh  was appointed as Director & Chief Executive Officer of All India Institute of Medical Sciences, Bhopal by the Government of India in June 2018 and after more than 3.5 years of outstanding work at the AIIMS, Bhopal he retired in November 2021.

He provided his services as to establish the Medical Sciences and Engineering Services (MEDSER) Centre, and as its founder Mentor and Adjunct Professor at IISER (INI under Ministry of Education), Bhopal from December 2021 to March 2024. The aim to establish the MEDSER Centre was carry forward his dream to enhance the collaboration between the faculties of medical and Engineering/ basic science institutions in the Madhya Pradesh state when he was the Director of AIIMS, Bhopal. In between he also served for short period of 4.5 months as Director (Academics) at  the Jaipur National University, Jaipur.  In March he joined the Aarupadai Veedu Medical College (AVMC), Pondicherry as Director Medical Research and Institutional Collaborations. The management of Vinayaka Mission Research Foundation (VMRF) has given him this challenging task of enhancing the medical research and innovation and quality of the publications. Dr Singh strongly believes that clinical research and quality publications enhance the perception of people about that medical college and hospital. 

He is an able hospital administrator, a loved teacher and dedicated researcher of international repute. Dr. Singh is listed in the world’s top 2% scientists for the last 4 consecutive years. Dr Singh has been the member and chairman of various animal and human ethics committees since 1999 till date. Prof. Singh has been the grant reviewer for various International and national funding agencies. A few of these are: Medical Research Council, Government of South Africa; Ministry of Science and Technology, Life Sciences Division. Government of Israel; Ministry of Health (General Direction for Scientific Research and Health Innovation), Italy; Ministry of Health, Federal Government of Germany; United Arab Emeritus University Grant, UAE; Medical Research Council (MRC)–Newton Fund, United Kingdom; Indian Council of Medical Research, India; Department of Biotechnology, India; Department of Sciences and Technology, India; Council for Scientific and Industrial Research, India; Biotech Consortium India Limited, India and Bill & Melinda Gates Foundation (IKP/BIRAC), India. Dr. Singh has 7 patents to his credit, and one technology commercialized, and taken-up by the Government of India in its kala-azar elimination programme. Another technology on developing a chimeric DNA dual vaccine for the control of Tuberculosis and Leishmaniasis is being actively considered by various commercial organizations. Yet another technology of developing novel protein biomarkers for rapid screening of active tuberculosis is also under consideration of commercialization. He is Fellow of more than 7 national and international Academies including Royal College of Pathologists and Royal Society of Chemists and Member of more than 20 national and international scientific bodies. He is Editor-in-chief of Journal of Laboratory Physicians, Editor of Medicine, PLoS-NTD, PLoS-One, and Tuberculosis Research and Treatment, besides being on the editorial boards of more than 40 national and international journals.

Prof. Singh has successfully undertaken more than 46 research projects from various national and international funding agencies including Department of Biotechnology (Government of India); Indian Council of Medical Research (Government of India); Department of Science and Technology (Govt of India); Indo-US Science and Technology Forum; Department of Health Research (Government of India); World Health Organization (Geneva); National Institute of Health (USA); and European Commission. The rapid diagnostic test (RDT) kits developed by his team for the diagnosis of Kala-azar or Visceral Leishmaniasis were taken up by the Government of India in its Kala-azar Elimination programme. His laboratory has recently made a revolutionary discovery in the field of TB detection, by identifying 5 novel proteins/antigens. These recombinant proteins are having sensitivity and specificity between 98.2% -100% and 89.1 – 98.2%, respectively. This innovation will be a game changer in the area of TB diagnostics not only for India but globally.

He has guided 36 PhD and DM scholars, 36 MD resident doctors and more than 40 MSc. students. He has written 6 books, 54 book chapters and more than 365 research papers in various peer reviewed journals, including the Lancet, Lancet Global Health, Lancet Infectious Diseases, Cell, PNAS, BMJ, to name a few; with a total citation of more than 14,000, i10 index of 227 and H-index of 63. Indeed Dr. Singh has several firsts to his credit, whether it pertains to new discoveries, novel innovations, finding new pathogens, clinical conditions, or disease manifestations. Most of his publication are on infectious diseases and particularly on Tuberculosis, Toxoplasmosis, Leishmaniasis and hepatitis viruses. (https://orcid.org/my-orcid?orcid=0000-0002- 0749-9647).